|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 80.19 EUR | -0.90% |
|
-0.40% | -3.06% |
| 03:27pm | SANOFI : UBS reaffirms its Neutral rating | ZD |
| 09/04 | Sanofi Now Holds Marketing Authorization for COVID-19 Vaccine Nuvaxovid in Canada | MT |
| Capitalization | 9.77TCr 11TCr 9.03TCr 8.52TCr 16TCr 10,56300Cr 16TCr 1,06600Cr 42TCr 5,09500Cr 43TCr 42TCr 18,19400Cr | P/E ratio 2026 * |
11.9x | P/E ratio 2027 * | 10.8x |
|---|---|---|---|---|---|
| Enterprise value | 11TCr 13TCr 10TCr 9.45TCr 18TCr 11,71700Cr 18TCr 1,18300Cr 46TCr 5,65200Cr 48TCr 47TCr 20,18300Cr | EV / Sales 2026 * |
2.33x | EV / Sales 2027 * | 2.12x |
| Free-Float |
87.31% | Yield 2026 * |
5.26% | Yield 2027 * | 5.59% |
Last Transcript: Sanofi
| 1 day | -0.90% | ||
| 1 week | -0.40% | ||
| Current month | -3.06% | ||
| 1 month | +5.08% | ||
| 3 months | -2.69% | ||
| 6 months | -3.78% | ||
| Current year | -3.06% |
| 1 week | 79.61 |  | 83.42 |
| 1 month | 75.33 | | 83.77 |
| Current year | 74.85 | | 84.97 |
| 1 year | 74.85 | | 98.36 |
| 3 years | 74.85 | | 110.88 |
| 5 years | 74.85 | | 110.88 |
| 10 years | 62.5 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 17/02/2026 | |
| Director of Finance/CFO | 63 | 01/04/2024 | |
Madeleine Roach
COO | Chief Operating Officer | 41 | 01/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Kron
BRD | Director/Board Member | 72 | 01/05/2014 |
| Director/Board Member | 60 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 28/04/2020 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.21% | 3.66% | 158 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.90% | -0.40% | -9.95% | -21.00% | 11TCr | |
| -1.64% | +1.59% | +30.64% | +156.62% | 85TCr | |
| -0.74% | -0.37% | +61.46% | +46.10% | 58TCr | |
| -0.98% | +1.83% | +20.82% | +30.50% | 38TCr | |
| -0.72% | 0.00% | +35.09% | +15.85% | 32TCr | |
| -0.30% | +1.82% | +52.03% | +30.95% | 32TCr | |
| -0.92% | +0.98% | +57.36% | +8.37% | 30TCr | |
| -0.34% | +1.64% | +43.74% | +40.20% | 30TCr | |
| -0.84% | +3.18% | +25.61% | +40.88% | 19TCr | |
| -0.89% | +0.46% | +38.83% | +70.42% | 18TCr | |
| Average | -0.78% | +0.32% | +35.56% | +41.89% | 35.31TCr | |
| Weighted average by Cap. | -0.90% | +0.69% | +39.21% | +62.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.66TCr 5.45TCr 4.31TCr 4.06TCr 7.54TCr 5,03800Cr 7.71TCr 51TCr 20TCr 2,43000Cr 20TCr 20TCr 8,67700Cr | 4.95TCr 5.79TCr 4.57TCr 4.31TCr 8TCr 5,35000Cr 8.19TCr 54TCr 21TCr 2,58100Cr 22TCr 21TCr 9,21500Cr |
| Net income | 863.5Cr 1.01TCr 798.19Cr 752.58Cr 1.4TCr 93TCr 1.43TCr 9.42TCr 3.67TCr 45TCr 3.79TCr 3.71TCr 1,60800Cr | 947.78Cr 1.11TCr 876.1Cr 826.03Cr 1.53TCr 1,02500Cr 1.57TCr 10TCr 4.03TCr 49TCr 4.16TCr 4.07TCr 1,76500Cr |
| Net Debt | 1.07TCr 1.25TCr 987.26Cr 930.84Cr 1.73TCr 1,15500Cr 1.77TCr 12TCr 4.54TCr 56TCr 4.69TCr 4.59TCr 1,98900Cr | 706.1Cr 826.05Cr 652.7Cr 615.4Cr 1.14TCr 76TCr 1.17TCr 7.7TCr 3TCr 37TCr 3.1TCr 3.03TCr 1,31500Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | 80.19 € | -0.90% | 20,27,807 |
| 09/26/09 | 80.92 € | +0.06% | 29,05,738 |
| 08/26/08 | 80.87 € | +0.45% | 40,90,098 |
| 07/26/07 | 80.51 € | -2.51% | 24,77,075 |
| 02/26/02 | 82.58 € | -0.35% | 19,94,015 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition